Four Swedish cases of CSF1R-related leukoencephalopathy: Visualization of clinical phenotypes.

CSF1R gene adult-onset leukoencephalopathy with spheroids and pigmented glia biomarkers colony stimulating factor 1 receptor neurodegeneration primary microgliopathy

Journal

Acta neurologica Scandinavica
ISSN: 1600-0404
Titre abrégé: Acta Neurol Scand
Pays: Denmark
ID NLM: 0370336

Informations de publication

Date de publication:
May 2022
Historique:
revised: 04 01 2022
received: 16 11 2021
accepted: 18 01 2022
pubmed: 5 2 2022
medline: 6 4 2022
entrez: 4 2 2022
Statut: ppublish

Résumé

Colony stimulating factor 1 receptor (CSF1R)-related leukoencephalopathy is a rare, genetic disease caused by heterozygous mutations in the CSF1R gene with rapidly progressive neurodegeneration, behavioral, cognitive, motor disturbances. To describe four cases of CSF1R-related leukoencephalopathy from three families with two different pathogenic mutations in the tyrosine kinase domain of CSF1R and to develop an integrated presentation of inter-individual diversity of clinical presentations. This is an observational study of a case series. Patients diagnosed with CSF1R encephalopathy were evaluated with standardized functional estimation scores and subject to analysis of cerebrospinal fluid biomarkers. Brain computed tomography (CT) and magnetic resonance imaging (MRI) were evaluated. We performed a functional phosphorylation assay to confirm the dysfunction of mutated CSF1R protein. Two heterozygous missense mutations in the CSF1R gene were identified, c.2344C>T; p.Arg777Trp and c.2329C>T; p.Arg782Cys. A phosphorylation assay in vitro showed markedly reduced autophosphorylation in cells expressing mutations. According to ACMG criteria, both mutations were pathogenic. A radiological investigation revealed typical white matter lesions in all cases. There was inter-individual diversity in the loss of cognitive, motor-neuronal, and extrapyramidal functions. Including the present cases, currently three CSF1R mutations are known in Sweden. We present a visualization tool to describe the clinical diversity, with potential use for longitudinal follow-up for this and other leukoencephalopathies.

Identifiants

pubmed: 35119108
doi: 10.1111/ane.13589
pmc: PMC9304267
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

599-609

Subventions

Organisme : Stockholm County Council
ID : ALF 20160457
Organisme : Biogen
Organisme : Novartis
Organisme : Merc
Organisme : Vigil Neuro

Informations de copyright

© 2022 The Authors. Acta Neurologica Scandinavica published by John Wiley & Sons Ltd.

Références

J Neurochem. 2017 Apr;141(2):296-304
pubmed: 27787906
JAMA Neurol. 2013 Jul;70(7):875-882
pubmed: 23649896
Sci Rep. 2015 May 15;5:10042
pubmed: 25975230
Psychol Med. 1997 Mar;27(2):363-70
pubmed: 9089829
Brain Pathol. 2014 Sep;24(5):452-8
pubmed: 24428556
Neurology. 1983 Nov;33(11):1444-52
pubmed: 6685237
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Neurology. 2012 Aug 7;79(6):566-74
pubmed: 22843259
Nat Rev Neurol. 2018 Oct;14(10):577-589
pubmed: 30171200
Acta Neuropathol Commun. 2020 Dec 7;8(1):217
pubmed: 33287883
Nat Genet. 2011 Dec 25;44(2):200-5
pubmed: 22197934
Acta Neuropathol Commun. 2015 Jul 04;3:42
pubmed: 26141825
Eur Neurol. 1996;36(5):268-72
pubmed: 8864706
Acta Neurol Scand. 2022 May;145(5):599-609
pubmed: 35119108
Eur J Neurol. 2016 Apr;23(4):817-22
pubmed: 26756564
J Neurol. 2021 Sep;268(9):3212-3222
pubmed: 32447549
J Neurol Sci. 1999 Oct 31;169(1-2):13-21
pubmed: 10540002
Neurogenetics. 2014 Oct;15(4):289-94
pubmed: 25012610
Eur J Neurol. 2017 Jan;24(1):37-45
pubmed: 27680516
Am J Hum Genet. 2019 May 2;104(5):925-935
pubmed: 30982609
Trends Neurosci. 2016 Jun;39(6):378-393
pubmed: 27083478
Brain. 2020 Feb 1;143(2):503-511
pubmed: 31840744
Neurology. 2018 Oct 16;91(16):755-757
pubmed: 30217938
Am J Med Genet B Neuropsychiatr Genet. 2012 Dec;159B(8):951-7
pubmed: 23038421
Front Neurol. 2019 Jan 18;9:1167
pubmed: 30713520
Acta Neuropathol Commun. 2019 Nov 27;7(1):188
pubmed: 31775912
Mov Disord. 2007 Jan;22(1):41-7
pubmed: 17115387
Curr Opin Neurol. 2016 Jun;29(3):254-62
pubmed: 27075495
Acta Neurol Scand. 2015;132(199):11-9
pubmed: 26046553
Brain. 2001 May;124(Pt 5):962-73
pubmed: 11335698
Mult Scler. 2019 Nov;25(13):1781-1790
pubmed: 30334474
J Neurol Sci. 2013 Nov 15;334(1-2):192-5
pubmed: 24034409
Eur J Neurol. 2018 Jan;25(1):142-147
pubmed: 28921817
Monaldi Arch Chest Dis. 2012 Sep;78(3):155-9
pubmed: 23614330
Neurology. 2013 Mar 12;80(11):1033-40
pubmed: 23408870
Neurol Sci. 2018 Apr;39(4):705-716
pubmed: 29427168
Mov Disord. 2021 Apr;36(4):852-856
pubmed: 33590562
J Neurol. 2018 Oct;265(10):2415-2424
pubmed: 30136118
J Neurol Neurosurg Psychiatry. 2016 May;87(5):512-9
pubmed: 25935893
J Am Geriatr Soc. 1992 Sep;40(9):922-35
pubmed: 1512391
J Neurol Sci. 2012 Jul 15;318(1-2):115-8
pubmed: 22503135
Parkinsonism Relat Disord. 2013 Oct;19(10):869-77
pubmed: 23787135
Cell Rep. 2020 Mar 3;30(9):3004-3019.e5
pubmed: 32130903
Lancet Neurol. 2019 Jun;18(6):573-586
pubmed: 30981640
Neurology. 2018 Dec 11;91(24):1092-1104
pubmed: 30429277

Auteurs

Igal Rosenstein (I)

Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of neurology, Region Västra Götaland, Södra Älvsborgs Hospital, Borås, Sweden.
Department of Neurology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.

Oluf Andersen (O)

Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Neurology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.

Daniel Victor (D)

Department of Neurology, Halmstad Hospital, Halmstad, Sweden.

Elisabet Englund (E)

Neuropathology, Department of Genetics and Pathology, Laboratory Medicine, Lund, Sweden.

Tobias Granberg (T)

Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden.
Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.

Carola Hedberg-Oldfors (C)

Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.

Katarina Jood (K)

Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Neurology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.

Yusran Ady Fitrah (YA)

Brain Research Institute, Niigata University, Niigata, Japan.

Takeshi Ikeuchi (T)

Brain Research Institute, Niigata University, Niigata, Japan.

Virginija Danylaité Karrenbauer (V)

Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Medical Unit Neuro R52, Karolinska University Hospital, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH